Research Topics
| Douglas YoungSummaryAffiliation: Imperial College Country: UK Publications
| Collaborators
|
Detail Information
Publications
Creativity in tuberculosis research and discoveryDouglas Younga
Division of Mycobacterial Research, MRC National Institute for Medical Research, London, UK
Tuberculosis (Edinb) 92:S14-6. 2012..Current trends towards improved experimental and computational approaches for studying biological complexity will be an important element in the developing science of TB vaccinology...
Genetic determination of the effect of post-translational modification on the innate immune response to the 19 kDa lipoprotein of Mycobacterium tuberculosisKatalin A Wilkinson
National Institute for Medical Research, Mill Hill, London, UK
BMC Microbiol 9:93. 2009..We also reintroduced the 19 kDa gene in two modified forms that lacked motifs for acylation (Delta19::19NA) and O-glycosylation (Delta19::19NOG)...
Bovine tuberculosis at a cattle-small ruminant-human interface in Meskan, Gurage region, Central EthiopiaRea Tschopp
Swiss Tropical and Public Health Institute, PO Box, CH 4002, Basel, Switzerland
BMC Infect Dis 11:318. 2011..The aim of this study was to assess BTB prevalence at an intensive contact interface in Meskan Woreda (district) in cattle, small ruminants and suspected TB-lymphadenitis (TBLN) human patients...
Systems biology of persistent infection: tuberculosis as a case studyDouglas Young
Centre for Integrative Systems Biology at Imperial College, Imperial College London, London SW7 2AZ, UK
Nat Rev Microbiol 6:520-8. 2008..In this article, we use Mycobacterium tuberculosis as an example of how systems-biology approaches have begun to make strides in uncovering important facets of the host-pathogen interaction...
Prospects for molecular epidemiology of leprosyDouglas Young
CMMI, Flowers Building, Imperial College London, UK
Lepr Rev 74:11-7. 2003
Animal models of tuberculosisDouglas Young
Division of Mycobacterial Research, MRC National Institute for Medical Research, London, UK
Eur J Immunol 39:2011-4. 2009..There clearly are major differences between experimental infection of mice and natural infection of humans, but this overarching dogma is inconducive to fruitful research...
The development and impact of tuberculosis vaccinesDouglas Young
Imperial College, University of London, South Kensington Campus, London SW7 2AZ, United Kingdom
Cell 124:683-7. 2006..But developing a new effective vaccine will require innovation in scientific research, a proactive approach to clinical trials of new vaccine candidates, and application of vaccines as part of an integrated approach to disease control...
Detection and treatment of subclinical tuberculosisBrian D Robertson
Rapporteur, Imperial College London, MRC Centre for Molecular Bacteriology and Infection, Flowers Building, South Kensington Campus, London SW7 2AZ, UK
Tuberculosis (Edinb) 92:447-52. 2012..The Working Group met in Cape Town on 26th February 2012, following presentation of results from the GC11 Grand Challenges in Global Health project to discover drugs for latent TB...
Non-coding RNA and its potential role in Mycobacterium tuberculosis pathogenesisKristine Arnvig
Division of Mycobacterial Research, MRC National Institute for Medical Research, London, UK
RNA Biol 9:427-36. 2012..We have reviewed emerging information on the presence and abundance of different types of non-coding RNA in M. tuberculosis and consider their potential contribution to the adaptive responses that underlie disease pathogenesis...
Mycobacterium tuberculosis and its ability to resist immunityDouglas Young
Imperial College London, South Kensington Campus, London, UK
Novartis Found Symp 281:169-77; discussion 177-80, 208-9. 2007..We explore here the hypothesis that genetic diversity of Mycobacterium tuberculosis provides an opportunity to tilt this balance in favour of the pathogen through variations in innate immune signalling...
Natural killer cells are recruited during pulmonary tuberculosis and their ex vivo responses to mycobacteria vary between healthy human donors in association with KIR haplotypeDamien Portevin
Division of Mycobacterial Research, MRC National Institute for Medical Research, The Ridgeway, Mill Hill, London, UK
Cell Microbiol 14:1734-44. 2012..tuberculosis infection...
Human macrophage responses to clinical isolates from the Mycobacterium tuberculosis complex discriminate between ancient and modern lineagesDamien Portevin
Mycobacterial Research Division, MRC National Institute for Medical Research, London, United Kingdom
PLoS Pathog 7:e1001307. 2011..In addition to the lineage effects, the large strain-to-strain variation in innate immune responses elicited by MTBC will need to be considered in tuberculosis vaccine development...
Chronic bacterial infections: living with unwanted guestsDouglas Young
Centre for Molecular Microbiology and Infection, Imperial College of Science, Technology and Medicine, London SW7 2AZ, UK
Nat Immunol 3:1026-32. 2002..Bacteria appear to adapt their immediate environment to favor survival and may hijack essential immunoregulatory mechanisms designed to minimize immune pathology or the inappropriate activation of immune effectors...
Organ specificity, colonization and clearance dynamics in vivo following oral challenges with the murine pathogen Citrobacter rodentiumSiouxsie Wiles
Centre for Molecular Microbiology and Infection, Department of Biological Sciences, Imperial College London, London SW7 2AZ, UK
Cell Microbiol 6:963-72. 2004..A bioluminescent eae (encoding the outer membrane adhesin intimin) C. rodentium mutant failed to establish long-term colonization, although low levels of bacteria could be recovered for up to 3 days post challenge from the caecum...
Systems biology could help us harness useful microbesDouglas Young
Nature 442:627. 2006
Conquistadors and Mycobacterium bovisDouglas Young
Tuberculosis (Edinb) 83:277-8. 2003
The 19-kDa Mycobacterium tuberculosis protein induces macrophage apoptosis through Toll-like receptor-2Martin Lopez
Department of Medicine, Division of Infectious Diseases, University of British Columbia, Faculty of Medicine and Science, The Research Institute of the Vancouver Hospital and Health Sciences Center, Vancouver, British Columbia, Canada
J Immunol 170:2409-16. 2003....
